Immunity Nutraceutical Ingredient Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 171 Category: Food and Beverages Report Code : FB116878
Immunity Nutraceutical Ingredient Market By Type (Phytochemical and plant extracts, Minerals, Omega-3 fatty acids, Fibers & specialty carbohydrates, and Carotenoids) and Application (Personal care, Functional beverages, Functional food, Dietary supplements, and Animal nutrition) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Immunity Nutraceutical Ingredient Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Nutraceutical ingredients are gotten from sources, for example, creature, plant, microbial, and engineered, which give medical advantages, including the essential healthy benefit and practical advantages to different applications, for example, nourishment, drinks, dietary enhancements, creature sustenance, and individual consideration items.
Drivers and Restraints
Expanding interest for invigorated nourishment inferable from the rising wellbeing awareness among individuals and orders on nourishment stronghold by government affiliations are a portion of the variables fuelling the market development. In any case, greater expenses of sustained items forestalling huge scale use are controlling the market development.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Tate & Lyle PLC
- Ingredion Incorporated
- Ajinomoto Co., Inc.
- Koninklijke DSM N.V.
- Arla Foods
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Immunity Nutraceutical Ingredient Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Phytochemical and plant extracts
o Minerals
o Omega-3 fatty acids
o Fibers & specialty carbohydrates
o Carotenoids
· Immunity Nutraceutical Ingredient Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Personal care
o Functional beverages
o Functional food
o Dietary supplements
o Animal nutrition
· Immunity Nutraceutical Ingredient Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Tate & Lyle PLC
o Ingredion Incorporated
o Ajinomoto Co., Inc.
o Koninklijke DSM N.V.
o Arla Foods
· Immunity Nutraceutical Ingredient Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Immunity Nutraceutical Ingredient Market, By Country
o U.S. Immunity Nutraceutical Ingredient Market
o Canada Immunity Nutraceutical Ingredient Market
o Mexico Immunity Nutraceutical Ingredient Market
o Europe
§ Europe Immunity Nutraceutical Ingredient Market, By Country
o Germany Immunity Nutraceutical Ingredient Market
o UK Immunity Nutraceutical Ingredient Market
o France Immunity Nutraceutical Ingredient Market
o Russia Immunity Nutraceutical Ingredient Market
o Italy Immunity Nutraceutical Ingredient Market
o Rest of Europe Immunity Nutraceutical Ingredient Market
o Asia-Pacific
§ Asia-Pacific Immunity Nutraceutical Ingredient Market, By Country
o China Immunity Nutraceutical Ingredient Market
o Japan Immunity Nutraceutical Ingredient Market
o South Korea Immunity Nutraceutical Ingredient Market
o India Immunity Nutraceutical Ingredient Market
o Southeast Asia Immunity Nutraceutical Ingredient Market
o Rest of Asia-Pacific Immunity Nutraceutical Ingredient Market
o South America
§ South America Immunity Nutraceutical Ingredient Market
o Brazil Immunity Nutraceutical Ingredient Market
o Argentina Immunity Nutraceutical Ingredient Market
o Columbia Immunity Nutraceutical Ingredient Market
o Rest of South America Immunity Nutraceutical Ingredient Market
o Middle East and Africa
§ Middle East and Africa Immunity Nutraceutical Ingredient Market
o Saudi Arabia Immunity Nutraceutical Ingredient Market
o UAE Immunity Nutraceutical Ingredient Market
o Egypt Immunity Nutraceutical Ingredient Market
o Nigeria Immunity Nutraceutical Ingredient Market
o South Africa Immunity Nutraceutical Ingredient Market
o Rest of MEA Immunity Nutraceutical Ingredient Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Immunity Nutraceutical Ingredient Market, By Type
5.1. Introduction
5.2. Global Immunity Nutraceutical Ingredient Revenue and Market Share by Type (2017-2027)
5.2.1. Global Immunity Nutraceutical Ingredient Revenue and Revenue Share by Type (2017-2027)
5.3. Phytochemical and plant extracts
5.3.1. Global Phytochemical and plant extracts Revenue and Growth Rate (2017-2027)
5.4. Minerals
5.4.1. Global Minerals Revenue and Growth Rate (2017-2027)
5.5. Omega-3 fatty acids
5.5.1. Global Omega-3 fatty acids Revenue and Growth Rate (2017-2027)
5.6. Fibers & specialty carbohydrates
5.6.1. Global Fibers & specialty carbohydrates Revenue and Growth Rate (2017-2027)
5.7. Carotenoids
5.7.1. Global Carotenoids Revenue and Growth Rate (2017-2027)
6. Immunity Nutraceutical Ingredient Market, By Application
6.1. Introduction
6.2. Global Immunity Nutraceutical Ingredient Revenue and Market Share by Application (2017-2027)
6.2.1. Global Immunity Nutraceutical Ingredient Revenue and Revenue Share by Application (2017-2027)
6.3. Personal care
6.3.1. Global Personal care Revenue and Growth Rate (2017-2027)
6.4. Functional beverages
6.4.1. Global Functional beverages Revenue and Growth Rate (2017-2027)
6.5. Functional food
6.5.1. Global Functional food Revenue and Growth Rate (2017-2027)
6.6. Dietary supplements
6.6.1. Global Dietary supplements Revenue and Growth Rate (2017-2027)
6.7. Animal nutrition
6.7.1. Global Animal nutrition Revenue and Growth Rate (2017-2027)
7. Immunity Nutraceutical Ingredient Market, By Region
7.1. Introduction
7.2. Global Immunity Nutraceutical Ingredient Revenue and Market Share by Regions
7.2.1. Global Immunity Nutraceutical Ingredient Revenue by Regions (2017-2027)
7.3. North America Immunity Nutraceutical Ingredient by Countries
7.3.1. North America Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2027)
7.3.2. North America Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Immunity Nutraceutical Ingredient by Countries
7.4.1. Europe Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2027)
7.4.2. Europe Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Immunity Nutraceutical Ingredient by Countries
7.5.1. Asia-Pacific Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Immunity Nutraceutical Ingredient by Countries
7.6.1. South America Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2027)
7.6.2. South America Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Immunity Nutraceutical Ingredient by Countries
7.7.1. Middle East and Africa Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Tate & Lyle PLC
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Ingredion Incorporated
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Ajinomoto Co., Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Koninklijke DSM N.V.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Arla Foods
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
9. Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.1. Global Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Immunity Nutraceutical Ingredient Market Forecast by Regions (2017-2027)
9.2.1. North America Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.1.1. United States Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.1.2. Canada Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.1.3. Mexico Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2. Europe Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.1. Germany Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.2. France Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.3. UK Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.4. Russia Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.5. Italy Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3. Asia-Pacific Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.1. China Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.2. Japan Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.3. Korea Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.4. India Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.4. South America Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.4.1. Brazil Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.4.2. Argentina Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.4.3. Columbia Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.4.4. Rest of South America Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5. Middle East and Africa Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.3. Egypt Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.4. Nigeria Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.5. South Africa Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.6. Turkey Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Immunity Nutraceutical Ingredient Market Forecast (2017-2027)
9.3. Immunity Nutraceutical Ingredient Market Forecast by Type (2017-2027)
9.3.1. Immunity Nutraceutical Ingredient Forecast by Type (2017-2027)
9.3.2. Immunity Nutraceutical Ingredient Market Share Forecast by Type (2017-2027)
9.4. Immunity Nutraceutical Ingredient Market Forecast by Application (2017-2027)
9.4.1. Immunity Nutraceutical Ingredient Forecast by Application (2017-2027)
9.4.2. Immunity Nutraceutical Ingredient Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Immunity Nutraceutical Ingredient Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Immunity Nutraceutical Ingredient Revenue and Revenue Share by Type (2017-2018)
Figure Global Phytochemical and plant extracts Revenue and Growth Rate (2017-2018)
Figure Global Minerals Revenue and Growth Rate (2017-2018)
Figure Global Omega-3 fatty acids Revenue and Growth Rate (2017-2018)
Figure Global Fibers & specialty carbohydrates Revenue and Growth Rate (2017-2018)
Figure Global Carotenoids Revenue and Growth Rate (2017-2018)
Table Global Immunity Nutraceutical Ingredient Revenue and Revenue Share by Application (2017-2018)
Figure Global Personal care Revenue and Growth Rate (2017-2018)
Figure Global Functional beverages Revenue and Growth Rate (2017-2018)
Figure Global Functional food Revenue and Growth Rate (2017-2018)
Figure Global Dietary supplements Revenue and Growth Rate (2017-2018)
Figure Global Animal nutrition Revenue and Growth Rate (2017-2018)
Table Global Immunity Nutraceutical Ingredient Revenue by Regions (2017-2018)
Figure North America Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure North America Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2018)
Figure North America Immunity Nutraceutical Ingredient by Countries (2017-2018)
Figure North America Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2018)
Figure United States Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure United States Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Canada Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Mexico Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Europe Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2018)
Figure Europe Immunity Nutraceutical Ingredient by Countries (2017-2018)
Figure Europe Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2018)
Figure Germany Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Germany Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure France Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure UK Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Russia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Italy Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Rest of Europe Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Asia-Pacific Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Immunity Nutraceutical Ingredient by Countries (2017-2018)
Figure Asia-Pacific Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2018)
Figure China Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure China Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Japan Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Korea Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure India Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Southeast Asia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure South America Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2018)
Figure South America Immunity Nutraceutical Ingredient by Countries (2017-2018)
Figure South America Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Brazil Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Argentina Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Columbia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Rest of South America Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Middle East and Africa Immunity Nutraceutical Ingredient Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Immunity Nutraceutical Ingredient by Countries (2017-2018)
Figure Middle East and Africa Immunity Nutraceutical Ingredient Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Saudi Arabia Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure United Arab Emirates Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Egypt Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Nigeria Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure South Africa Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Turkey Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunity Nutraceutical Ingredient Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2017-2018)
Table Tate & Lyle PLC Immunity Nutraceutical Ingredient Financial Overview
Table Ingredion Incorporated Immunity Nutraceutical Ingredient Financial Overview
Table Ajinomoto Co., Inc. Immunity Nutraceutical Ingredient Financial Overview
Table Koninklijke DSM N.V. Immunity Nutraceutical Ingredient Financial Overview
Table Arla Foods Immunity Nutraceutical Ingredient Financial Overview
Figure Global Immunity Nutraceutical Ingredient Revenue (Millions USD) and Growth Rate (2018-2025)
Table Immunity Nutraceutical Ingredient Market Forecast by Regions (2018-2025)
Figure North America Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure United States Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Canada Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Mexico Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Europe Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Germany Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure France Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure UK Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Russia Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Italy Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Rest of Europe Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Asia-Pacific Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure China Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Japan Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Korea Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure India Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Southeast Asia Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure South America Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Brazil Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Argentina Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Columbia Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Rest of South America Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Middle East and Africa Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Saudi Arabia Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure United Arab Emirates Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Egypt Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Nigeria Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure South Africa Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Turkey Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Immunity Nutraceutical Ingredient Market Forecast (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Forecast by Type (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Market Share Forecast by Type (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Forecast by Type (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Forecast by Application (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Market Share Forecast by Application (2018-2025)
Figure Global Immunity Nutraceutical Ingredient Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|